Abstract
Cancer is a leading cause of death worldwide. Tumor cells exploit various signaling pathways to promote their growth and metastasis. To our knowledge, the role of angiopoietin-like 4 protein (ANGPTL4) in cancer remains undefined. Here, we found that elevated ANGPTL4 expression is widespread in tumors, and its suppression impairs tumor growth associated with enhanced apoptosis. Tumor-derived ANGPTL4 interacts with integrins to stimulate NADPH oxidase-dependent production of O2-. A high ratio of O2-:H2O2 oxidizes/activates Src, triggering the PI3K/PKBα and ERK prosurvival pathways to confer anoikis resistance, thus promoting tumor growth. ANGPTL4 deficiency results in diminished O2- production and a reduced O2-:H2O2 ratio, creating a cellular environment conducive to apoptosis. ANGPTL4 is an important redox player in cancer and a potential therapeutic target.
Original language | English |
---|---|
Pages (from-to) | 401-415 |
Number of pages | 15 |
Journal | Cancer Cell |
Volume | 19 |
Issue number | 3 |
DOIs | |
Publication status | Published - Mar 8 2011 |
Externally published | Yes |
ASJC Scopus Subject Areas
- Oncology
- Cell Biology
- Cancer Research